ILMN

4 Top Efficient Stocks to Buy for Stellar Returns

A company with a favorable efficiency level is expected to provide stellar returns as it is believed to be positively correlated with its price performance. Com....

3 Stocks to Watch on Wednesday: Edwards Lifesciences Corp (EW), Illumina, Inc. (ILMN) and Tesla Inc (TSLA)

Edwards Lifesciences (EW) and Illumina (ILMN) reported their quarterly earnings results, while Tesla (TSLA) is being accused of stiffing its workers of overtime.

3 Stocks to Watch on Wednesday: Illumina, Inc. (ILMN), Juniper Networks, Inc. (JNPR) and Stryker Corporation (SYK)

Illumina (ILMN) earnings were 22 cents above expectations, Juniper Networks's (JNPR) revenue above $5 billion for 2017 and Stryker's (SYK) income swings to a loss.

7 A-Rated Healthcare Stocks to Buy

It may be all about taxes now, but 2018 is all about healthcare. The following are some of the best healthcare stocks to buy in 2018.

Shares of Illumina (ILMN) Raised to Strong Buy From a Buy

Illumina Inc (NASDAQ:ILMN) is ranked as a Strong Buy using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. ILMN has been upgraded from a Buy to a Strong Buy in the last week.

Illumina (ILMN) a Buy on Superior Earnings Growth

Currently, Illumina Inc (NASDAQ:ILMN) has a Buy using the approach to investing of Louis Navellier and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking ILMN has had from Portfolio Grader for the last month.

Illumina’s (ILMN) High-Level Earnings Visibility Keep it a Buy

Portfolio Grader currently ranks Illumina Inc (NASDAQ:ILMN) a Buy. The approach to investing incorporated in this analytical tool developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. This represents no change from the previous week and is the same ranking ILMN has had from Portfolio Grader for the last month.

Illumina’s (ILMN) Strong Earnings Visibility Keep it a Buy

Illumina Inc (NASDAQ:ILMN) is one of the 782 companies in the GICS Health Care sector, and a component of the 33 company Life Sciences Tools & Services GICS industry group within this sector. ILMN has a market value of $30.5 billion which is in the top decile in its industry group. Portfolio Grader's current ranking for ILMN puts it 6 among the 33 companies in this industry group, placing it among the leaders; among the sector leaders with a ranking of 75 among the 782 companies in the sector, and number 530 in the nearly 5,000 company Portfolio Grader universe.

Illumina (ILMN) a Buy on High-Level Sales Growth

Illumina Inc (NASDAQ:ILMN) ranks in the top 10% of its industry group, Life Sciences Tools & Services, and in the top 10% of its sector group, Health Care, with a market value of $31.2 billion. From an investment attractiveness vantage point, ILMN is ranked in the top decile of the sector with a ranking of 73 among the 785 companies in the sector; Portfolio Grader's current ranking for ILMN puts it 8 among the 33 companies in this industry group, giving it a well above-average position and number 528 in the 5000 company Portfolio Grader company universe.

Illumina’s (ILMN) Solid Sales Growth Keeps it a Buy

The current recommendation of Buy for Illumina Inc (NASDAQ:ILMN) is computed using Louis Navellier's Portfolio Grader stock evaluator, which incorporates his investing methodology. ILMN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Earnings Momentum Keeps Illumina (ILMN) a Buy

Illumina Inc (NASDAQ:ILMN) is ranked as a Buy using the system for investing of Louis Navellier and his Portfolio Grader stock evaluator. ILMN has recently seen its Portfolio Grader rating upgraded from a Hold to a Buy.

Metrics for Sales Growth Drive Upgrade of Illumina (ILMN) to Buy

Currently, Illumina Inc (NASDAQ:ILMN) has a Buy using Louis Navellier's investing methods and his Portfolio Grader stock evaluator. The shares have been upgraded from a Hold to a Buy in the last week.

Illumina (ILMN) Shares Raised to Buy

The current recommendation of Buy for Illumina Inc (NASDAQ:ILMN) is derived using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. The shares have been upgraded from a Hold to a Buy in the last week.

Illumina (ILMN) Shares Raised to Buy

The current recommendation of Buy for Illumina Inc (NASDAQ:ILMN) is derived using Louis Navellier's methodology for investing and his Portfolio Grader stock evaluator. The shares have been upgraded from a Hold to a Buy in the last week.

4 Tech Stocks You Should “BITE” Into

If you’re looking to profit from large-cap tech stocks, forget the FANGs, FAANGs and FAAMGs. This quartet offers more to "BITE" down on.

3 Pharma Stocks That Will Inject New Life Into Your Portfolio

These three pharma stocks all have the potential to deliver fantastic gains despite the industry’s turmoil.

4 Tech Stocks Showing More Bite Than the FANGs

The FANGs have been awesome performers, but BIDU, ILMN, TSLA and EA may have more "bite" for investors to sink their teeth into.

3 Pharmaceutical Stocks to Sell Before They Take a Dive

Investors looking to add pharmaceutical stocks to their portfolios should avoid these three because they are facing strong headwinds.

3 Stocks That Will Benefit From Good Relations With China

AAPL, LVS and ILMN stood to lose a great deal from a deterioration in U.S.-China relations, so they will be celebrating this week's talks.